TMEM229A and non-small cell lung carcinoma: For instance, in non-small cell lung cancer (NSCLC), transmembrane protein (TMEM) 229A (TMEM229A) is significantly underexpressed, and this underexpression is associated with poor prognosis in patients with cancer.